Phytoplant Research

What Phytoplant Research does

Phytoplant Research S.L.U. is a Spanish privately-held R&D company founded in 2008 and headquartered at the Rabanales 21 Science and Technology Park in Córdoba. It operates across the full Cannabis sativa L. industrial value chain — genetic improvement, cultivation, extraction, purification, and analytical quality control — and was the first company in Spain to receive an AEMPS permit to conduct medical and scientific cannabis research. The company's commercial offering rests on three pillars: (i) a catalogue of 14 proprietary cannabis varieties registered with the EU Community Plant Variety Office (CPVO), covering medicinal (high-THC, high-CBD, high-CBG, CBDV), industrial, and ornamental chemotypes; (ii) patented extraction and purification processes — including supercritical fluid extraction, crystallization (ES 9765000 B2) achieving >95% purity, and liquid-liquid chromatography (ES 10207199 B2) — available for license; and (iii) technical assistance and regulatory consultancy spanning project conceptualization, technology watch, third-party auditing, and full production-project design.

The business model is asset-light and B2B, monetizing IP through licensing royalties on varieties and patents, one-off plant material sales from the registered catalogue, and fee-based professional services. Pricing is quote-based with multi-year contracts. Customers are enterprise buyers in pharmaceutical, nutraceutical, dermocosmetic, and industrial hemp segments across Europe, with selective international reach (a USPTO plant patent for the Divina ornamental variety and a research partnership with UNAM). Scientific authority is reinforced through peer-reviewed publications and a dense network of academic collaborators including Universidad de Córdoba, CSIC, IFAPA, IRTA, UPO, UPF, UCA, and UAM.

The company is led by a PhD-heavy scientific team — General Manager Dr. Carlos Ferreiro (analytical chemistry, UCO), Extraction Director Dr. Verónica Sánchez, Analytical Chemistry Director Dr. María Teresa García, Systems Director Jesús Hidalgo, Breeding and Cultivation Director Dr. Juan José Martínez, and Finance Director Mª Ángeles Pieri — supported by researchers and a recently hired classical breeder, Dr. Roberto Moreno Pinel (2024). Phytoplant holds ISO 9001, ISO 14001, and UNE 166002 certifications and PYME INNOVADORA status valid through October 2027. The firm is privately held with no disclosed external investors, parent company, or subsidiaries, and operates from a single Córdoba site with 23 employees.

Name

Phytoplant Research

Legal name

PHYTOPLANT RESEARCH, S.L.U.

Website

https://phytoplant.es

Company type

Private

Founded year

2008

Operating status

Operating

Short description

Phytoplant Research is a Spanish cannabis R&D company that breeds, registers, and licenses 14 proprietary Cannabis sativa L. varieties and patented purification processes, serving pharmaceutical, nutraceutical, dermocosmetic, and industrial hemp producers through licensing, consulting, and plant material sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Córdoba

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Licensed Plant Varieties: Revenue generated from licensing proprietary cannabis varieties to cultivators and producers. All varieties have intellectual property rights exploitable through license agreements.
2. Licensable Technologies: Revenue from licensing patented extraction and purification technologies and processes to third parties for commercial production of cannabis-derived products.
3. Technical Assistance and Consulting: Technical assistance services including project conceptualization, regulatory consultancy, third-party auditing, and support in design and implementation of production and extraction projects.
4. Plant Material Sales: Sale of proprietary cannabis varieties from the company's registered variety catalogue for cultivation and production purposes.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Phytoplant Research develops and licenses proprietary Cannabis sativa L. varieties (14 varieties registered with the EU Community Plant Variety Office) and patented extraction and purification technologies (crystallization and chromatography methods achieving >95% purity). It provides technical assistance, project conceptualization, regulatory consultancy, and R&D services spanning breeding, cultivation, extraction, and quality control for pharmaceutical, nutraceutical, and dermocosmetic companies developing cannabis-derived products.

Product overview

Phytoplant Research operates as a research and development company specializing in the Cannabis sativa L. industrial chain. The company offers a portfolio of 14 proprietary cannabis varieties (registered with CPVO) available through licensing, along with patented extraction and purification technologies. Their services span the entire production chain from genetic improvement and breeding through cultivation, extraction, and quality control, with particular focus on medicinal, nutraceutical, and dermocosmetic applications. The company provides technical assistance, regulatory consultancy, and production technology development services to clients seeking to enter the cannabis-derived products market.

Differentiator

Problem solved

Functional benefit

Products and services

• Variety Catalogue (Registered Cannabis sativa L. Varieties) Proprietary Cannabis sativa L. varieties with registered intellectual property rights, available for exploitation through license agreements. The catalogue includes medicinal varieties (high THC, high CBD, high CBG chemotypes) and industrial hemp varieties for pharmaceutical, nutraceutical, and industrial customers.
• Licensable Technology (Patented Extraction and Purification Processes) Patented technologies for cannabinoid extraction and purification processes available for licensing, including crystallization (achieving >95% purity) and chromatography-based purification methods (CCC, CPC, and Flash chromatography) for pharmaceutical applications.
• Technical Assistance Services Technical assistance for project conceptualization, technology watch, third-party auditing, and regulatory consultancy to support clients in developing cannabis-derived products and manufacturing processes.
• Production Technology Development Assistance in defining and developing complete production projects from conceptualization through successful completion of productive permits, including cultivation, harvesting, drying, and extraction processes.
• Breeding and Cultivation Research Services Genetic improvement program using hybridization (crossing) of different lines from their seed bank to create new genetic combinations with added market value, including marker-assisted selection and in vitro tissue culture techniques.
• Extraction Research Services Research and development in extraction of active principles, terpenes, and fatty acids with potential application in pharmaceutical, nutraceutical, and dermocosmetic sectors, utilizing supercritical fluids, organic solvents, steam distillation, and cold pressing.
• Quality Control and Analytical Services Analytical technology for detection and quantification of cannabinoids, terpenes, flavonoids, and other molecules of pharmacological or industrial interest, ensuring quality control of raw materials, intermediate and final products.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Universidad Pablo de Olavide (UPO)coreStrategic or Co-development PartnerAcademic partnership for joint research projects in plant genetics and biotechnology, providing access to university research facilities and scientific expertise.
• Universitat Pompeu Fabra (UPF)coreStrategic or Co-development PartnerAcademic collaboration in biomedical and pharmacological research related to cannabis-derived compounds and their mechanisms of action.
• Universidad Nacional Autónoma de México (UNAM)coreStrategic or Co-development PartnerInternational academic partnership for collaborative research on cannabis genetics and plant biology.
• Universidad de Córdoba (UCO)coreStrategic or Co-development PartnerPrimary academic partner located in the same region as company headquarters, providing research collaboration in analytical chemistry, genetics, and plant sciences. Multiple company team members hold degrees and doctorates from this institution.
• Universidad de Cádiz (UCA)minorStrategic or Co-development PartnerAcademic partnership for collaborative research projects in agricultural sciences and plant biology.
• Universidad Autónoma de Madrid (UAM)minorStrategic or Co-development PartnerAcademic collaboration in biomedical research related to cannabis pharmacology.
• Junta de AndalucíacoreStrategic or Co-development PartnerRegional government partnership providing institutional support, research funding, and collaboration through agencies such as Agencia Andaluza de la Energía. Company received EU NextGenerationEU funding for photovoltaic self-consumption through this partnership.
• Institut de Recerca i Tecnologia Agroalimentàries (IRTA)minorStrategic or Co-development PartnerCatalan agricultural research institute partnership for crop science and cultivation optimization research.
• Consejo Superior de Investigaciones Científicas (CSIC)coreStrategic or Co-development PartnerNational research council partnership including collaboration with the Instituto de Agricultura Sostenible (IAS) for genetic improvement and plant breeding research.
• CICAP (Centro de Investigación de la Cárcava)minorStrategic or Co-development PartnerAgricultural research center partnership for field trials and cultivation research.
• CIOPORA (International Community for the Protection of Horticultural Creations)coreOthersInternational association for the protection of horticultural plant varieties, supporting Phytoplant's intellectual property rights for registered cannabis varieties.
• ANOVE (Spanish Association of Plant Breeders)coreOthersNational breeders association supporting Phytoplant's plant variety protection and breeding program activities.
• DEVECanminorChannel Partner/ Reseller/ DistributorCommercial partnership for cannabis-derived product distribution and market development.
• SiquimiaminorChannel Partner/ Reseller/ DistributorChemical products distributor partnership for laboratory reagents and supplies.
• Fundación CannaminorStrategic or Co-development PartnerCannabis research foundation partnership for scientific knowledge exchange and research collaboration.
• Pharma-OriginsminorStrategic or Co-development PartnerPharmaceutical industry partnership for product development and commercialization of cannabis-derived compounds.
• IFAPA (Instituto Andaluz de Investigación y Formación Agraria, Pesquera, Alimentaria y de la Producción Ecológica)coreStrategic or Co-development PartnerRegional agricultural research institute collaboration for field trials and agronomic studies, including multi-year cultivation experiments in Mediterranean environments.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bedrocan: Dutch medical cannabis producer with standardized, pharmacopoeia-grade cannabis varieties supplied to multiple EU countries. Highly comparable to Phytoplant's model of supplying registered, quality-controlled cannabis genetics and APIs to institutional pharmaceutical buyers.

Broad incumbents

• Jazz Pharmaceuticals (GW Pharmaceuticals): Owns the Sativex/Epidiolex franchises and is the most established pharmaceutical-grade cannabis company. Comparable as a buyer and adjacent developer of standardized, regulatory-compliant cannabinoid APIs that Phytoplant supplies technology and genetics toward.
• Tilray Brands: Large multi-jurisdiction cannabis operator with proprietary genetics, medical cannabis brands (including in Europe via Tilray Medical), and cultivation/processing capabilities. Operates a similar B2B genetics and medical-cannabis supply proposition at much larger scale.
• Canopy Growth Corporation: Global cannabis operator with branded medical cannabis (Spectrum Therapeutics), genetics programs, and EU operations. Comparable as a broad incumbent pursuing standardized, IP-protected cannabis varieties for pharmaceutical and consumer health applications.
• Aurora Cannabis: Canadian licensed producer with EU GMP-certified cultivation, a medical cannabis division (Aurora Medical), and proprietary genetics. Comparable as a vertically integrated cannabis operator serving EU pharma and patient markets.
• OrganiGram Holdings: Canadian cannabis producer with a focus on derivative products, R&D, and medical-grade supply. Comparable as a research-driven cannabis company investing in genetics, processing IP, and pharmaceutical-grade outputs.
• Cronos Group: Global cannabis operator with branded medical and consumer product lines. Comparable as a broad incumbent investing in cannabinoid science and proprietary formulations across nutraceutical and pharmaceutical adjacencies.

Emerging players

• MediPharm Labs: GMP-certified cannabis extraction and API specialist focused on supplying pharmaceutical-grade cannabinoids to third parties. Highly comparable in business model as a B2B cannabis processor whose capabilities overlap with Phytoplant's extraction and purification technology.
• Charlotte's Web Holdings: US hemp-derived CBD wellness company with proprietary genetics and branded nutraceutical/dermocosmetic products. Comparable in its use of registered hemp varieties and standardized cannabinoid profiles for nutraceutical and topical applications.
• Demecan: German vertically integrated medical cannabis producer covering cultivation, processing, and distribution. Comparable as a European-focused B2B medical cannabis operator that would be a natural licensee of Phytoplant's EU-registered varieties and processing IP.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/phytoplant_es
• Facebookfacebook.com/Phytoplant-Research-378333125957065
• LinkedInlinkedin.com/company/phytoplantresearch

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phytoplant Research